Oct 01, 09:07
AnnouncementsAbbott India: Updates on outcome of AGM
100% of moneycontrol users recommend buying Abbott India.
What's your call on Abbott India today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.00||-0.90||3353.85||2420.00||54,517.07|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||602,981|
|Reliance Pharma Fund (G)||385,001|
|Reliance Long Term Equity Fund (G)||155,254|
|Reliance Tax Saver (ELSS) Fund (G)||65,530|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Abbott India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 6,825.59 crore.The company has reported a standalone sales of Rs 478.55 crore and a Net Profit of Rs 38.40 crore for the quarter ended Mar 2014.
The company management includes Munir Shaikh - Chairman, Rehan A Khan - Managing Director, Kaiyomarz Marfatia - Whole Time Director, Rajendra Shah - Independent Director, Ashok Dayal - Independent Director, Ranjan Kapur - Independent Director, Bhaskar lyer - Additional Director, Sachin Dharap - Additional Director, Valentine Yien - Additional Director.
It is listed on the BSE with a BSE Code of 500488 and the NSE with an NSE Code of ABBOTINDIA.
Its Registered office is at 3/4, Corporate Park, Sion Trombay Road,,Chembur Mumbai,Maharashtra - 400071.
Their Registrars are Sharepro Services (India) Pvt.Ltd.